SCHEMBL1820249

SCHEMBL1820249

COc1ccc(S(=O)(=O)N2CCOc3ccc(-c4ccc(C#N)s4)cc32)cc1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ KMT2A Q03164 4/20 0.42
▸ MAPT P10636 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ TP53 P04637 1/20 0.42
▸ NPC1 O15118 2/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ PKM P14618 3/20 0.38
▸ PKLR P30613 2/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ CPT1A P50416 5/20 0.38
▸ CPT1B Q92523 4/20 0.38
▸ CPT2 P23786 3/20 0.38
▸ USP2 O75604 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.36
▸ HSD17B1 P14061 1/20 0.36
▸ HSD17B2 P37059 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1819897 0.89 MEN1 (0.42) POLBCYP3A4CYP2D6KMT2AMAPT
SCHEMBL1818514 0.87 TSHR (0.42) POLBCYP3A4CYP2D6KMT2AMAPT
SCHEMBL1818459 0.86 POLB (0.47) POLBCYP3A4CYP2D6KMT2AMAPT
SCHEMBL12818531 0.85 PKM (0.45) CYP3A4CYP2D6KMT2AMEN1NPC1
SCHEMBL1817694 0.85 POLB (0.46) POLBCYP3A4CYP2D6KMT2AMAPT
SCHEMBL1818909 0.84 PKM (0.48) KMT2AMEN1NPC1CYP2C9PKM
SCHEMBL1818674 0.84 CYP2C9 (0.53) KMT2AMAPTMEN1TP53NPC1
SCHEMBL1816713 0.83 MAPT (0.41) KMT2AMAPTCPT1ACPT1BCPT2
SCHEMBL1818704 0.83 NPC1 (0.41) POLBCYP3A4CYP2D6KMT2AMAPT
SCHEMBL1820750 0.81 CYP2C9 (0.42) CYP3A4CYP2D6KMT2AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO claimed
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO disclosed
Send feedback